Association of the metabolic syndrome with intracranial atherosclerotic stroke.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 16043803.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate the impact of metabolic syndrome (MetSD) on the development of intracranial atherosclerotic stroke, the authors evaluated the components of the MetSD in 512 patients with stroke. The MetSD was observed most frequently in patients with intracranial atherosclerosis (p = 0.007). In multiple regression analysis, the MetSD, but not conventional risk factors, was independently associated with intracranial atherosclerosis (p = 0.005). The results suggest that treatment of metabolic abnormalities may be an important prevention strategy for intracranial atherosclerosis.
Medical subject headings
- Intracranial Arteriosclerosis
- Metabolic Syndrome
- Stroke